Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2077921 | Cell Stem Cell | 2011 | 4 Pages |
Abstract
The cell therapy branch of the regenerative medicine field has been innovative in developing new models of delivery and development and identifying alternative sources of funding. We discuss the implications of these changes for pharmaceutical companies and the opportunities they offer to a new entrepreneur.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Mahendra S. Rao,